Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
Abstract Tuberculosis (TB) remains a global health problem and there is an ongoing effort to develop more effective therapies and new combination regimes that can reduce duration of treatment. The purpose of this study was to demonstrate utility of a physiologically‐based pharmacokinetic modeling ap...
Guardado en:
Autores principales: | Helen Humphries, Lisa Almond, Alexander Berg, Iain Gardner, Oliver Hatley, Xian Pan, Ben Small, Mian Zhang, Masoud Jamei, Klaus Romero |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f55df4e4fa5444cbd1301d827c62ac4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically‐based pharmacokinetic model
por: Khaled Abduljalil, et al.
Publicado: (2021) -
Alzheimer's disease: Newer biomarkers
por: Ankit Dangi, et al.
Publicado: (2021) -
History, evolution and newer perspectives of rabies vaccines
por: K. Vijayakumar, et al.
Publicado: (2021) -
Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
por: Ricardo E. Steffen, et al.
Publicado: (2020) -
A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
por: Maneesha Peter, et al.
Publicado: (2020)